C. Meds for Parkinsonism and AD Flashcards
parkinsonism patho
Pathophysiology
- Chronic neurologic disorder
- Degeneration of
dopaminergic neurons
•Imbalance of the neurotransmitters
•Less dopamine
Parkinsonism characteristics
•
Tremors of head and neck
- Rigidity(increased muscle tone)
- Bradykinesia(slow movement)
- Postural changes
- Head and chest thrown forward
- Shuffling walk
- Lack of facial expression
- Pill-rolling motion of hands
Parkinsonism treatment
Treatment regimen
- Dopaminergics
- Convert to dopamine
•Dopamine agonists
•Stimulate dopamine receptors
•Anticholinergics
•Block cholinergic receptors
•MAO-B inhibitors
Inhibit MAO-B enzyme that interferes with dopamine
•COMT inhibitors
•Inhibit COMT enzyme that inactivates
dopamine
Dopaminergic -
Carbidopa-levodopa (Sinemet)
action
- Action: converted to dopamine
- Short duration of action—must be taken 3 or 4 times per day. Extended release 2 to 4 times/day
- Side effects
- Involuntary choreiform movements
- N & V, Urinary retention
- Fatigue, insomnia, dry mouth, blurred vision
- Orthostatic hypotension, palpitations, dysrhythmias
- Dyskinesia, psychosis, severe depression
- Drug interactions
- Phenytoin, Benzodiazepines,Anticholinergics
antiparkinsonism drugs-
nurse interventions
- Nursing interventions
- Do not abruptly discontinue (safety issue)
- Monitor for orthostatic hypotension
- Avoid excess vitamin B6
- Warn of urine/sweat getting harmless brown discoloration
- Assess symptom status and “on-off”phenomenon
- Monitor blood cell counts, liver function &
kidney function (BUN & Creatinine)
•Teaching re: anticholinergic
effects with Benztropine
& Trihexyphenidyl
Alzheimer’s Disease AD
Patho
- Progressive, degenerative disease
- Neuritic plaques form
- Neurofibrillary tangles are in neurons
- Cholinergic neurotransmitter abnormality
Alzheimer’s Disease AD:
characteristics
- Loss of memory, logical thinking, judgment
- Time disorientation
- Personality changes
- Hyperactivity
- Tendency to wander
- Inability to express oneself
Meds to treat AD
- Acetylcholinesterase Inhibitors: donepezil (Aricept), rivastigmine (Exelon), tacrine (Cognex)
- Use
- Mild to moderate Alzheimer’s disease
- Goal
- NOT a cure
- Improve memory
- Slow progression of disease
AD med SE
Headache, dizziness, Dehydration, dry
mouth, Blurred vision, Depression, GI
distress, Insomnia, Hypertension,
hypotension, dysrhythmias, Hepatotoxicity
AD med-
NI
- Monitor vital signs
- Maintain consistency in care
- Monitor behavioral changes
- •Provide safety*
- when wandering*
- •Arise slowly to avoid dizziness*
•Monitor for GIbleeding